Inhibitors of the CD95 signaling pathway for treatment of MDS

• 收藏
• 分享

专利权人:

Apogenix GmbH

发明人:

Fricke, Harald,Fontenay, Michaela

申请号：

AU2013291981

公开号：

AU2013291981A1

申请日:

2013.07.18

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention relates to inhibitors of the CD95 signaling pathway for the use in the treatment of Myelodysplastic Syndrom (MDS) wherein the MDS is selected from the IPSS low risk MDS subgroup and/or the IPSS intermediate-1 (int-1 ) risk MDS subgroup as well as a method for the diagnosis of MDS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/